James Nnaji
Story Poster
Slow Start, Cold Finish Doom Baylor in 80–62 Loss at Kansas
1 mo ago by Levi Caraway
Baylor men’s basketball (11-6, 1-4) was blown out in frustrating fashion, 80-62, by the Kansas Jayhawks (13-5, 3-2) on Friday night at Allen Fieldhouse.
Story Poster
Roundtable: What Has Gone Wrong for Baylor Men's Basketball and How to Move Forward?
1 mo ago by SicEm365 Staff
SicEm365.com's Ashley Hodge, Levi Caraway and Jack Mackenzie are joined by Baylor Basketball expert Kendall Kaut to take a closer look at why Scott Drew's Bears are off to an 0-3 start in Big 12 play and what has to change moving forward.
Story Poster
Baylor Basketball Falls to Frogs 69-63 in James Nnaji's Debut, Big 12 Opener
1 mo ago by Jack Mackenzie
The Bears fell behind by as many as 12 points before mounting a late comeback to cut the deficit to 66-63, but fell short in the end.
Story Poster
Presser: Drew, Rataj & Williams Answer Questions Ahead of Baylor's Big 12 Opener
1 mo ago by SicEm365 Staff
Head coach Scott Drew, guard Isaac Williams and forward Michael Rataj answered questions ahead of the Bears' Saturday afternoon game at rivals TCU.
Story Poster
22:29
The Bear Cast: Reactions to Baylor Basketball's Addition of James Nnaji
1 mo ago by SicEm365 Staff
On today's episode, Grayson Grundhoefer and Ashley Hodge react to Baylor Basketball announcing the addition of former NBA draft pick James Nnaji to the Bears for the current season.
Story Poster
Presser: Drew Talks Addition of James Nnaji Ahead of Final Tune-Up Before Big 12 Play
1 mo ago by SicEm365 Staff
Head coach Scott Drew answers questions about the midseason addition of James Nnaji ahead of the final tune-up game against Arlington Baptist before Big 12 play begins.
Story Poster
Baylor Adds Midseason Transfer, James Nnaji, to Help Bolster Big Man Rotation
1 mo ago by Ashley Hodge
Baylor’s men basketball has received a commitment from Nigerian center James Nnaji.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.